MGC Pharmaceuticals' "numbers were very good" in Q4 2022 | News Direct

MGC Pharmaceuticals' "numbers were very good" in Q4 2022

MGC Pharmaceuticals Ltd
News release by MGC Pharmaceuticals Ltd

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | February 08, 2023 08:47 AM Eastern Standard Time

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner about how the business performed during the fourth quarter of 2022. Clements says that the "numbers were very good" and reveals more details about how the business is changing as it heads into a new calendar year.

Proactive UK Finance News

 

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com